SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
International Differences in Drug Prices
15 references·0 citing·42 second hop
International Differences in Drug Prices (2004)International Differences in Drug PricesMedicare Current Beneficiary Survey (2016)Medicare Current Beneficiary …Pharmaceutical Industry Profile (2005)Pharmaceutical Industry Profi…Dilemmas In Regulation Of The Market For Pharmaceuticals (2003)Dilemmas In Regulation Of The…Should the US allow prescription drug reimports from Canada? (2002)Should the US allow prescript…Pharmaceuticals and the Developing World (2002)Pharmaceuticals and the Devel…Drug development for neglected diseases: a deficient market and a public-health policy failure (2002)Drug development for neglecte…Prescription Drug Prices: Why Do Some Pay More Than Others Do? (2001)Prescription Drug Prices: Why…Cross-national price differences for pharmaceuticals: how large, and why? (2000)Cross-national price differen…Chapter 12 Health insurance and the labor market (2000)Chapter 12 Health insurance a…International Price Comparisons for Pharmaceuticals (1998)International Price Compariso…Health Insurance and the Labor Market (1998)Health Insurance and the Labo…Differential Pricing and Efficiency (1996)Differential Pricing and Effi…Competitive Strategies in the Pharmaceutical Industry (1996)Competitive Strategies in the…Industrial Market Structure and Economic Performance. (1971)Industrial Market Structure a…Industrial Market Structure and Economic Performance (1971)Industrial Market Structure a…The Economics of Imperfect Competition. (1933)Microeconomic Analysis. (1968)Incentives: Motivation and the Economics of Information (1995)Price Discrimination and Social Welfare (2000)Aggregation and Disaggregation of Information Goods: Implications for Bundling, Site Licensing,and Micropayment Systems (2001)Privacy, economics, and price discrimination on the Internet (2003)The Changing Relation between Mortality and level of Economic Development (1975)The Role of Wages and Auditing during a Crackdown on Corruption in the City of Buenos Aires (2003)Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)Developing Drugs For Developing Countries (2006)The pattern and causes of economic growth in India (2007)Patents and the Global Diffusion of New Drugs (2015)Male-Female Wage Differentials in Urban Labor Markets (1973)Labor Market Discrimination Against Hispanic and Black Men (1983)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Does Regulation Drive Out Competition in Pharmaceutical Markets? (2000)The Hedonic Method (2003)Parallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)Human Development Report 2001: Making new technologies work for human development (2001)Intellectual property rights, the WTO and developing countries: the TRIPS agreement and policy options (2001)25 years of the WHO essential medicines lists: progress and challenges (2003)HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAM (2005)The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment (2013)Job Matching and the Theory of Turnover (1979)Chapter 12 The theory of equalizing differences (1986)Minimum Wages and Employment: A Case Study of the Fast-Food Industry in New Jersey and Pennsylvania: Reply (2000)Health Insurance, Labor Supply, and Job Mobility: A Critical Review of the Literature (2002)The incidence of the healthcare costs of obesity (2009)Bankruptcy as Implicit Health Insurance (2015)Are product and Process Innovations Independent of Each Other? (1990)An Inquiry into Well-Being and Destitution (1995)Corporate structure, ownership and the likelihood of innovation (1996)PUBLIC POLICY SOURCES (2004)Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How? (2008)Sectoral patterns of technical change: Towards a taxonomy and a theory (1984)First-mover advantages (1988)Sources, Procedures, and Microeconomic Effects of Innovation (2000)Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development (2013)Making Up Is Hard to Do: Knowledge Acquisition Strategies and the Nature of New Product Innovation (2015)Career concerns with exponential learning (2017)Chapter 3 Medical care prices and output (2000)Follow-on biologics: data exclusivity and the balance between innovation and competition (2008)
this work references cited by second hop

References

  • 1971Industrial Market Structure and Economic Performance.6,267 cited
  • 2002Drug development for neglected diseases: a deficient market and a public-health policy failure895 cited
  • 2002Pharmaceuticals and the Developing World323 cited
  • 2000Cross-national price differences for pharmaceuticals: how large, and why?285 cited
  • 1998Health Insurance and the Labor Market215 cited
  • 1971Industrial Market Structure and Economic Performance190 cited
  • 1996Differential Pricing and Efficiency146 cited
  • 2005Pharmaceutical Industry Profile113 cited
  • 2001Prescription Drug Prices: Why Do Some Pay More Than Others Do?111 cited
  • 1996Competitive Strategies in the Pharmaceutical Industry93 cited
  • 2000Chapter 12 Health insurance and the labor market86 cited
  • 2003Dilemmas In Regulation Of The Market For Pharmaceuticals85 cited
  • 2002Should the US allow prescription drug reimports from Canada?80 cited
  • 1998International Price Comparisons for Pharmaceuticals78 cited
  • 2016Medicare Current Beneficiary Survey76 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work